openPR Logo
Press release

Companion Animal Pharmaceuticals Market worth $19.6 billion by 2027

10-19-2023 02:00 PM CET | Health & Medicine

Press release from: Markets and Makets

Companion Animal Pharmaceuticals Market

Companion Animal Pharmaceuticals Market

Companion Animal Pharmaceuticals Market in terms of revenue was estimated to be worth $14.4 billion in 2022 and is poised to reach $19.6 billion by 2027, growing at a CAGR of 6.3% from 2022 to 2027 according to a new report by MarketsandMarkets™. Factors such as rising prevalence of zoonotic diseases, initiatives by various government agencies and animal associations, rising demand for pet insurance due to growing animal health expenditure, increasing R&D investments for animal healthcare, and high pet ownership rates worldwide are fueling this market.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=252218886&utm_source=OPenpr&utm_campaign=Paid&utm_content=Referral

The infectious diseases segment is expected to account for the largest share of the companion animal pharmaceuticals market in 2021

Based on indication, the global companion animal pharmaceuticals market is segmented into infectious diseases, orthopedic diseases, pain, dermatologic diseases, behavioral disorders, and other indications. The infectious diseases segment has the largest share of the market. The large share of this segment can be attributed to the growing regulatory guidelines to prevent the spread of infectious diseases is fueling the market growth, easy accessibility of these pharmaceuticals, rising initiatives by government and animal health associations for controlling disease outbreaks, and growing adoption rates of pet ownership.

On the basis of animal type, dogs segment is expected to grow at highest CAGR in the companion animal pharmaceuticals market during the forecast period

Based on animal type, the companion animal pharmaceuticals market is segmented into dogs, cats, horses/equine, and others. The dogs segment is projected to grow at the highest CAGR in the forecast period. This growth can be attributed to the rising dog population and increasing adoption rate of dogs, increasing skin allergies, rising canine healthcare expenditure, and the rising number of pet insurers worldwide.

The North America segment is expected to account for the largest share of the companion animal pharmaceuticals market in 2021

North America holds largest share in companion animal pharmaceuticals market 2021. The rising pet ownership and increasing animal health expenditure, rising per capita income in these countries, increasing awareness on animal healthcare, growing number of veterinary hospitals and clinics, and the implementation of regulations to prevent the spread of animal diseases are the key factors driving market growth in this region.

Request for FREE Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=252218886&utm_source=OPenpr&utm_campaign=Paid&utm_content=Referral

Key Market Players:

Major players operating in the companion animal pharmaceuticals market Zoetis Inc. (US), Merck & Co., Inc. (US), Boehringer Ingelheim GmbH (Germany), Elanco Animal Health Incorporated (US), Ceva Santé Animale (France), Virbac (France), Vetoquinol S.A. (France), Dechra Pharmaceuticals plc (UK) are some of the market players.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=252218886&utm_source=OPenpr&utm_campaign=Paid&utm_content=Referral

Recent Developments:

In November 2022, the company launched MOVOFLEX, a new joint supplement for dogs, in Europe

In January 2022, Zoetis received the US FDA Approval of Simparica Trio (sarolaner, moxidectin, and pyrantel chewable tablets), a new label Indication for the prevention of Borrelia burgdorferi Infections in dogs.

In July 2020, Merck acquired the US rights from Virbac for the SENTINEL brand of combination parasiticides used to protect dogs against fleas and common intestinal parasites.

In December 2020, Elanco entered into an agreement with Kindred Biosciences to acquire the exclusive global rights to KIND-030, a first-of-its-kind monoclonal antibody developed to treat and prevent canine parvovirus (CPV).

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Companion Animal Pharmaceuticals Market worth $19.6 billion by 2027 here

News-ID: 3256764 • Views:

More Releases from Markets and Makets

Enterprise Information Archiving Market Status, Revenue, Growth Rate, Services and Solutions
Enterprise Information Archiving Market Status, Revenue, Growth Rate, Services a …
According to a research report "Enterprise Information Archiving Market with COVID-19 Impact, by Type (Content Type (Email, Database, Social Media, Instant Messaging, Mobile Communication) and Services), Deployment Mode, Organization Size, Vertical & Region - Global Forecast to 2027" published by MarketsandMarkets, Download Report Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=253224202 The global enterprise information archiving market size is expected to grow at a Compound Annual Growth Rate (CAGR) of 15.2% during the forecast period, to
Animal Wound Care Market Worth $2.0 Billion | Elanco Animal Health (US), 3M Company (US)
Animal Wound Care Market Worth $2.0 Billion | Elanco Animal Health (US), 3M Comp …
Animal Wound Care market in terms of revenue was estimated to be worth $1.3 billion in 2023 and is poised to reach $2.0 billion by 2028, growing at a CAGR of 7.4% from 2023 to 2028 according to a latest report published by MarketsandMarkets™. The animal wound care market is poised for sustained growth by factors such as growing awareness of animal health, rising cost of veterinary care, rising pet
Tax Management Market Global Trends, Size, Segments and Growth by Forecast to 2027
Tax Management Market Global Trends, Size, Segments and Growth by Forecast to 20 …
The global Tax Management Market is projected to grow to USD 35.1 billion by 2027 from USD 21.0 billion in 2022 at a Compound Annual Growth Rate (CAGR) of 10.8% during the forecast period. Download Report Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=230446693 Standardization of tax compliance processes to scale operations globally, minimize risks, and fulfill tax obligations with lesser effort, increase in transparency for tax audits, and automation compliance tasks with AI, ML, and provision
The specialty food ingredients market is poised for substantial growth driven by consumer preferences for healthier and innovative food options
The specialty food ingredients market is poised for substantial growth driven by …
According to a comprehensive research report titled "Specialty Food Ingredients Market," published by MarketsandMarkets, the market for specialty food ingredients is anticipated to witness significant growth in the forecast period. The report projects that the market, valued at USD 179.8 billion in 2023, is expected to reach USD 240.9 billion by 2028, with a Compound Annual Growth Rate (CAGR) of 6.0% during this period. This growth is attributed to various

All 5 Releases


More Releases for Animal

Animal Health Market Sets the Table for Continued Growth : Zoetis Animal Healthc …
Advance Market Analytics published a new research publication on "Animal Health Market Insights, to 2028" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Animal Health market was mainly driven by the increasing R&D spending across the world. Some of the key players profiled
Animal Antimicrobials and Antibiotics Market 2023 Growth and Development By Bion …
Antibiotics, also called antibacterials, are a type of antimicrobial drug used in the treatment and prevention of bacterial infections. They may either kill or inhibit the growth of bacteria. Animal Antimicrobials and Antibiotics includes Premixes, Oral Powders, Oral Solutions and Injections on the base of classification, which represent 12.4%, 14.4%, 10.4% and 56.6% of global Animal Antimicrobials and Antibiotics market. Get Sample Copy: https://www.worldwidemarketreports.com/sample/273708 Farm Animals and Companion Animals are the
Animal Healthcare Market Analysis Focusing on Top Key Players - Merck, Bayer Ani …
Worldwide Market Reports recently released on the Animal Healthcare market for the forecast period, 2017 – 2022 is involved in screening the business environment and the companies operating in the Animal Healthcare industry. Importantly, the research sheds a lot of light on their winning strategies to help stakeholders, business owners, and field marketing executives stay ahead in the competition. Besides, the industry is thoroughly weighed upon on the basis of
Animal Model Market trends, Animal Model Market growth, Animal Model Market size …
Key Findings of Animal Model Market Developing Regions to Overpower Developed Ones With Regard to Demand The Asian territory is on the verge of evolving as the next big destination for animal models. This growth can be attributed to various factors such as American and European pharmaceutical companies diversifying their research activities to curtail extra expenses and save costs. Although U.S and Europe have retained their legacy in the global market, their
Animal Growth Promoter Market Outlook To 2023 – Bayer Animal Health, Biomin, B …
Nov 2018, New York USA (News)- Different categories of feed additives for farm animals are referred to as natural growth promoters (NGPs) or non-antibiotic growth promoters. They are commonly regarded as favorable alternatives to antibiotic growth promoters (AGPs) in livestock production. NGPs include predominantly organic acids, probiotics, prebiotics, synbiotics, phytogenics, tannins, feed enzymes and immune stimulants, an ongoing search for alternatives has created a large variety of NGPs for pigs,
Animal Antimicrobials and Antibiotics Market Key Players : Animal Health, Bayer …
The term antibiotic or antimicrobial is used for those agents who kill or inhibit the growth of microorganism. The antimicrobials products have significant benefits to the animal and to human food safety. There are researches, which have proven that an increase in the rate of animal illness results in higher rate of human illness. Therefore, livestock dealers depend on animal antibiotics to provide safe food. The scope of this report